University Home | Hospital | Pulse Employment | Contact Us | Search | News 
Thomas Jefferson University Search Jefferson
Jefferson Medical College Jefferson College of Graduate Studies Jefferson College of Health Professions
Menu

For Patients & Families > Specific Diseases > Movement Disorders > Parkinson's Disease > Pure Potential

Pure Potential

Developing a pure dopamine cell line is a critical step in improving cell replacement
therapies for Parkinson’s. Farber Associate Director Lorraine Iacovitti and colleagues
have shown that it is possible to generate and isolate dopamine neurons from both
mice and human neural stem cells. Here’s what it took to do it:

1. Decode and clone the gene for tyrosine hydroxylase (TH), an enzyme that is needed for dopamine production by cells.
arrow
arrow

2. Insert cloned gene for TH into fertilized mouse eggs, attached to a gene for Green Fluorescent Protein (GFP), which causes “tagged” TH cells to glow green.
arrow

2. Insert cloned gene for TH into human neural stem cells (using a lentivirus), attached to a gene for Green Fluorescent Protein (GFP), which causes “tagged” TH cells to glow green.
arrow

3. When mice reach embryonic stage of development, micro-dissect out the green-tagged cells to obtain a high proportion of TH-positive (dopamine-producing) cells.
arrow
3. Apply growth factors and other nourishing biochemicals to induce the cells to differentiate into dopamine neurons.
arrow
4. Process the cells in a cell-sorting instrument to identify and remove any cells that are not dopamine-specific.
arrow
PURIFIED DOPAMINE CELLS FOR TRANSPLANTATION

Continue

Go Back




 Printable Version

Thomas Jefferson University
Farber Institute for Neurosciences